Arch Therapeutics, Inc. Annual Revenues in USD from 2011 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: Arch Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2011 to 2023.
Arch Therapeutics, Inc. Revenues for the quarter ending June 30, 2024 was $30.9K, a 133% increase year-over-year.
Arch Therapeutics, Inc. Revenues for the twelve months ending June 30, 2024 was $148K, a 292% increase year-over-year.
Arch Therapeutics, Inc. annual Revenues for 2023 was $75.7K, a 384% increase from 2022.
Arch Therapeutics, Inc. annual Revenues for 2022 was $15.7K, a 35.3% increase from 2021.
Arch Therapeutics, Inc. annual Revenues for 2021 was $11.6K.

Revenues, Trailing 12 Months (USD)

Revenues, Annual (USD)

Revenues, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$75.7K	+$60.1K	+384%	Oct 1, 2022	Sep 30, 2023	10-K	2024-02-15
2022	$15.7K	+$4.09K	+35.3%	Oct 1, 2021	Sep 30, 2022	10-K	2024-02-15
2021	$11.6K	+$11.6K		Oct 1, 2020	Sep 30, 2021	10-K	2022-12-28
2020	$0	$0		Oct 1, 2019	Sep 30, 2020	10-K	2021-12-17
2019	$0	$0		Oct 1, 2018	Sep 30, 2019	10-K	2020-12-11
2018	$0	$0		Oct 1, 2017	Sep 30, 2018	10-K	2019-11-19
2017	$0	$0		Oct 1, 2016	Sep 30, 2017	10-K	2018-12-18
2016	$0	$0		Oct 1, 2015	Sep 30, 2016	10-K	2017-11-15
2015	$0	$0		Oct 1, 2014	Sep 30, 2015	10-K	2016-12-05
2014	$0	$0		Oct 1, 2013	Sep 30, 2014	10-K	2015-12-11
2013	$0	$0		Oct 1, 2012	Sep 30, 2013	10-K	2014-12-12
2012	$0	$0		Oct 1, 2011	Sep 30, 2012	10-K/A	2014-05-01
2011	$0			Oct 1, 2010	Sep 30, 2011	10-K	2012-12-31

* An asterisk sign (*) next to the value indicates that the value is likely invalid.